And to date, we see this sort of operating as business usual, the type of information requests that we’re getting ... Are now docs being a lot more cautious in prescribing this in non ambulatory ...

The U.S. Food and Drug Administration has approved the humanized monoclonal antibody Zynyz (retifanlimab-dlwr) as the first first-line treatment for advanced anal cancer.